Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Sign up for alerts
  • About us
    • About Development
    • About the Node
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contacts
    • Subscriptions
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in
  • Log out

Search

  • Advanced search
Development
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Development

  • Log in
Advanced search

RSS  Twitter  Facebook  YouTube 

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Sign up for alerts
  • About us
    • About Development
    • About the Node
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contacts
    • Subscriptions
    • Feedback
Research Article
The metalloproteinase inhibitor Reck is essential for zebrafish DRG development
Andrew Prendergast, Tor H. Linbo, Tanya Swarts, Josette M. Ungos, Hillary F. McGraw, Shlomo Krispin, Brant M. Weinstein, David W. Raible
Development 2012 139: 1141-1152; doi: 10.1242/dev.072439
Andrew Prendergast
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tor H. Linbo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Swarts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Josette M. Ungos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hillary F. McGraw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shlomo Krispin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brant M. Weinstein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David W. Raible
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: draible@u.washington.edu
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Summary

The neural crest is a migratory, multipotent cell lineage that contributes to myriad tissues, including sensory neurons and glia of the dorsal root ganglia (DRG). To identify genes affecting cell fate specification in neural crest, we performed a forward genetic screen for mutations causing DRG deficiencies in zebrafish. This screen yielded a mutant lacking all DRG, which we named sensory deprived (sdp). We identified a total of four alleles of sdp, all of which possess lesions in the gene coding for reversion-inducing cysteine-rich protein containing Kazal motifs (Reck). Reck is an inhibitor of metalloproteinases previously shown to regulate cell motility. We found reck function to be both necessary for DRG formation and sufficient to rescue the sdp phenotype. reck is expressed in neural crest cells and is required in a cell-autonomous fashion for appropriate sensory neuron formation. In the absence of reck function, sensory neuron precursors fail to migrate to the position of the DRG, suggesting that this molecule is crucial for proper migration and differentiation.

INTRODUCTION

During normal embryonic development, cells are often generated in locations far removed from their place of differentiation. Cell migration is important in the formation of many tissues, and the dysregulation of migration has drastic consequences for embryos and adult organisms alike. Neural crest is a transient cell lineage that gives rise to tissues including but not limited to: cartilage and bone of the craniofacial skeleton, secretory neuroendocrine cells, pigment cells, and many of the neurons and glia of the peripheral nervous system (Le Douarin and Kalcheim, 1999). Neural crest is specified as a limited cell population at the lateral border of neural and non-neural ectoderm; it must then migrate in regulated phases and expand to generate these derivatives. All vertebrate taxa possess neural crest, and the mechanisms that distinguish neural crest from all other cell types are considered to have been critical in the origin and evolution of the vertebrate clade (Gans and Northcutt, 1983; Knecht and Bronner-Fraser, 2002).

The relationship between neural crest differentiation and migration is poorly understood. Most studies have identified molecules crucial to early events in migration, such as delamination from the neuroectoderm or maintenance of neural crest segmentation. However, little attention has been paid to the cues that terminate migration, an essential condition for appropriate neural crest cell differentiation. Furthermore, although studies have defined a handful of guidance factors and extracellular matrix cues that direct neural crest to its targets, it is unclear how these migratory cues interact with specific neural crest fate decisions.

Dorsal root ganglia (DRG) are a crest-derived, segmentally arrayed series of sensory neurons and their associated glia that detect pain, temperature, mechanical and proprioceptive stimuli. Expression of the Neurogenins (Neurog), a family of basic helix-loop-helix (bHLH) transcription factors, is currently the earliest known indicator of DRG neuronal identity (Greenwood et al., 1999; Ma et al., 1999; Perez et al., 1999). In the zebrafish, neurog1 is essential for the formation of DRG neurons (Andermann et al., 2002; Cornell and Eisen, 2002); in its absence, cells differentiate as myelinating Schwann cells (McGraw et al., 2008). Although Neurog transcription factors clearly determine sensory neuron identity, the mechanism by which their expression is initiated is unclear.

To identify genes implicated in the initial cell fate decisions in DRG, we conducted a mutant screen in the zebrafish for mutants lacking DRG sensory neurons. We isolated a mutant, sensory deprived (sdp), in which neural crest derivatives form normally with the exception of the DRG. Subsequent work mapped the associated mutation to the gene encoding Reck (reversion-inducing, cysteine-rich protein containing Kazal motifs), an inhibitor of metalloproteinases (Takahashi et al., 1998). reck has previously been implicated in the development of the mammalian cortex (Muraguchi et al., 2007) and circulatory system (Oh et al., 2001). In cell culture studies, loss of reck function is associated with a hypermigratory phenotype (Morioka et al., 2009; Silveira Corrêa et al., 2010), presumably because upregulated metalloproteinase activity allows cells to permeate the extracellular matrix more easily. This cell migratory behavior is reflected in studies of human cancers, which are more aggressive following Reck inactivation (Clark et al., 2007). Our results suggest a mechanistic link between termination of migration and initial differentiation of sensory neuron precursors from the neural crest.

MATERIALS AND METHODS

Zebrafish husbandry

Zebrafish were maintained at 28.5°C on a 14-hour/10-hour light/dark cycle following established methods and Institutional Animal Care and Use Committee standards (Westerfield, 2007). Embryos were maintained in E2 medium, and staged according to Kimmel et al. (Kimmel et al., 1995). DRG were identified using Tg(neurog1:egfp)w61 (McGraw et al., 2008).

Transgenic lines

The 4.9 kb sox10 promoter (Carney et al., 2006), fluorescent protein Eos (Wiedenmann et al., 2004) (Evrogen) or nls-Eos, and a polyadenylation sequence (Kwan et al., 2007) were Gateway cloned (Invitrogen) to generate pSox10:Eos/pSox10nls-Eos; clones were microinjected with Tol2 transposase to generate germline transgenics Tg(sox10:eos)w9 and Tg(sox10:nlseos)w18 as previously described (Fisher et al., 2006).

Immunohistochemistry

Embryos were stained with the antibodies mouse anti-Elavl1 (Invitrogen), 1:500; rabbit anti-GFP (Invitrogen) 1:1000; mouse anti-acetylated tubulin (Sigma; 1:5000), mouse anti-MF20 (Developmental Studies Hybridoma Bank, University of Iowa; 1:100), rabbit anti-Sox10 (gift of Sarah Kucenas, University of Virginia; 1:500), as previously described (Ungos et al., 2003) and imaged by confocal microscopy.

Genetic screen

We treated *AB males with 3 mM ethylnitrosourea (Solnica-Krezel et al., 1994). F3 progeny were screened by immunostaining for Elavl1. Sdpw15 was identified in the *AB background during screening. Three additional alleles were identified: sdpw13 by complementation screening against sdpw15 carriers and sdpw12 and sdpw14 isolated as novel mutations and later established as sdp alleles by complementation.

Mutation identification

sdpw12 heterozygotes were outcrossed to the Wik strain and F2 progeny were subjected to bulked segregant analysis using SSLP markers followed by analysis of individuals, as described (Bahary et al., 2004). Zebrafish reck sequence was generated by alignment of expressed sequence tags (ESTs) identified by BLAST search using Mus musculus RECK protein as the search string, and used as a template to clone the zebrafish cDNA by PCR. Staged embryos were homogenized in Trizol (Invitrogen), and total RNA was isolated by column purification (Qiagen). RNA was treated with DNAse I (Fermentas) to remove genomic DNA and reverse transcribed (Invitrogen). Amplicons were cloned into pCR4-TOPO (Invitrogen) and sequenced.

To identify sdpw12 mutant embryos, tissue was homogenized by overnight incubation in 200 μg/μl proteinase K. A 233 bp amplicon was PCR-amplified from genomic DNA using primers (F: 5′-GAATCTCCACCCATCGCCAAGATG-3′; R: 5′-GAATGTTAGCAGCTGTGAGGTTTG-3′) and digested with AvaII (NEB), which cuts the wild-type product.

Morpholino oligonucleotide knockdown

A splice-blocking morpholino oligonucleotide (MO) with the sequence CAGGTAGCAGCCGTCACTCACTCTC was generated based on prediction of efficacy by the manufacturer (Gene Tools). This MO targets the reck exon 7-intron 7 boundary. Injected embryos were processed for cDNA as above. We designed primers flanking intron 7 (F: 5′-CATCAACAACTCACTACCAGGAGC-3′, exon 7; R: 5′-GGGTGTAGTCTGGTGTAGTTCTCC-3′, exon 8) to detect appropriately spliced reck transcript.

Angiograms

Tg(fli1a:egfp)y1 embryos (Lawson and Weinstein, 2002) were injected at 48 hours post-fertilization (hpf) in the sinus venosus with a 40% solution of Qdot fluorescent nanocrystals (Invitrogen) as previously described (Kamei et al., 2010; Weinstein et al., 1995) and imaged using an Olympus FluoView FV-1000 confocal microscope.

mRNA injection

Wild-type (wt) and sdpw12 reck coding sequences were ligated into pCS2p+, linearized with NotI and transcribed in vitro with SP6 polymerase to generate capped, polyadenylated mRNA (Ambion). A range of mRNA concentrations was injected into embryos derived from a cross between Tg(neurog1:egfp)/sdpw12/+ parents. Data were analyzed using a two-factor ANOVA; post-hoc significance between conditions was determined using the Scheffé method.

In situ hybridization

Digoxigenin-labeled riboprobes for crestin (Rubinstein et al., 2000) and neurog1 (Korzh et al., 1998) were generated as previously described. A 2.1 kb fragment of reck was subcloned into pBluescript II SK, linearized with EcoRV and transcribed with T7 polymerase (Invitrogen) to generate digoxigenin-labeled riboprobe. In situ hybridization was carried out as previously described (Thisse and Thisse, 2008). Fluorescent in situ hybridization was carried out as previously described (Vize et al., 2009). Embryos were then embedded in 4% agarose and sectioned at 100 μm on a Leica VT1000S vibratome. Colocalization of reck and crestin was analyzed by confocal imaging in single optical planes sampled every 7 μm. The anterior-posterior position of each section was determined by alignment to the section containing the yolk constriction.

Metalloproteinase activity

Tg(neurog1:egfp)/sdpw12/+ parents were incrossed; the resulting embryos were sorted by phenotype at 48 hpf and homogenized in lysis buffer (150 mM NaCl, 10 mM HEPES, 2 mM DTT, 0.1% Triton X-100, pH 8.0). Protein concentration was normalized using the Bradford method. Lysate was incubated with DQ gelatin (Invitrogen) at room temperature; fluorescence was assayed using a fluorimeter (Tecan).

Transplants

Donor Tg(neurog1:egfp) embryos were injected with 1 nl 2.5% tetramethyl rhodamine dextran, 0.1 M KCl and either 1.75 μg/μl reck MO or sterile water. Host nacrew2/w2 embryos were injected at the one-cell stage with 1 nl 0.2% Phenol Red, 0.1 M KCl and either 1.75 μg/μl reck MO or sterile water. Donor and host embryos were dechorionated and mounted in 4% methylcellulose at sphere or dome stage (∼3.5-4.5 hpf). Cells were aspirated into a pulled capillary glass needle and deposited into host embryos. Transplants were allowed to recover in E2 media supplemented with 100 U penicillin/100 μg/ml streptomycin.

Neural crest migration measurements

Tg(sox10:eos)/sdpw12/+ fish were incrossed; the resulting clutch was fixed at 24 hpf, immunostained for MF20 and imaged by confocal microscopy. A threshold was applied to the images using Photoshop and images were then subjected to a MatLab (Mathworks) algorithm measuring the length of y-direction signal (i.e. first black pixel to last black pixel) for each x coordinate. This plot was smoothed by averaging over 10-point bins. Local maxima were detected by an iterative point-to-point comparison function (peakdet, http://billauer.co.il/peakdet.html).

Time-lapse microscopy and cell tracking

Tg(sox10:nls-eos) embryos (18 somite-stage; 18s) and Tg(sox10:nls-eos)/Tg(neurod:tagrfp)w69 embryos (30 hpf) were immobilized in 1.5% Type VII agarose (Sigma) and imaged every 10 minutes using a 3i Marianas spinning disk confocal microscope system. Image files were processed using Slidebook (3i) and ImageJ (NIH) software. Movies from the early interval were initiated at the beginning of neural crest migration. Movies from the late interval were synchronized so that the lateral line crosses somite 16 at the same frame. Divisions were identified by resolution of mitotic figures; cell death was determined by nuclear fragmentation.

Cell tracking was performed manually in ImageJ. Dorsoventral cell velocity was defined as the sum of y-axis displacements divided by the number of frames in which the cell was visible. Proliferative and apoptotic rates were defined by the following equation: Embedded Image where x is the number of events observed per time lapse, ncells is the total number of cells tracked and tframes is the number of frames (each separated by 10 minutes). Multiplying by 144 yielded the number of events per cell-day.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

sensory-deprived (sdp) mutants exhibit a complete loss of DRG sensory neurons. (A) Tg(neurog1:egfp) zebrafish embryos (3 dpf) immunostained for Elavl1. (A′) DRG are absent in an sdpw12/w12 mutant embryo. Scale bar: 500 μm. (B,B′) High magnification images of A and A′. Scale bar: 50 μm. (C,C′) neurog1 expression at 48 hpf. Box indicates position of high magnification images in D,D′. Scale bar: 250 μm. (D,D′) High magnification image of C and C′. Scale bar: 50 μm. Arrowheads indicate neurog+ DRG sensory neuron precursors. (E,E′) Tg(sox10:eos) embryo (3 dpf) immunostained for Elavl1. Although Schwann glia (empty arrowhead) are retained, satellite glia (filled arrowhead) are absent in sdpw12/w12. Scale bar: 25 μm. (F,F′) Counts of neurog1+ DRG at 3 dpf. Approximately 25% of embryos fail to form DRG, suggesting that sdpw12 is a fully penetrant recessive mutation. (G) Counts of neurog1+ DRG followed over four days. DRG never appear in ∼25% of the population, indicating that sdp does not delay in DRG development.

Drug experiments

Tg(neurog1:egfp)/sdpw12 embryos were treated in drug dissolved in 1% DMSO in E2 medium from 16s to 3 days post-fertilization (dpf); drug solution was changed daily. Embryos were fixed and immunostained for Elavl1 and GFP. Drugs were administered at the following concentrations: GM6001 (Enzi Life Sciences), 100 μM; batimastat (Tocris Biosciences), 500 μM; marimastat (Tocris Biosciences), 100 μM; DAPT (Sigma), 100 μM.

TUNEL staining

Fish were fixed at 30 hpf and immunostained with rabbit anti-Sox10 antibody. Embryos were permeabilized with 20 μg/ml proteinase K (Sigma) and subjected to TUNEL labeling using fluorescein substrate (Roche). TUNEL+ and Sox10+ cells were counted from confocal stacks and the embryos were subsequently genotyped.

RESULTS

sdp is a recessive phenotype involving the loss of DRG neurons

To identify mutations that alter DRG development, we screened for perturbed expression of Elavl1 in the peripheral nervous system (Henion et al., 1996; Marusich et al., 1994; Szabo et al., 1991). We identified four alleles of a recessive mutation, sensory deprived (sdp). All mutant embryos completely lack DRG up to and including 5 dpf (Fig. 1, supplementary material Fig. S1). However, for all mutations all other neural crest derivatives appear to develop normally (supplementary material Fig. S2), including pigment cells, enteric neurons, lateral line glia and sympathetic chain (supplementary material Fig. S2); although normal in morphology, the ceratohyal cartilage is displaced (supplementary material Fig. S2K-L′). Cranial ganglia, which have both neural crest and placode origin, appear normal (supplementary material Fig. S2) and have comparable cell counts (supplementary material Fig. S3). Fish homozygous for any of the sdp alleles die by day 12.

Mutant embryos display defects in DRG formation at the earliest stages of their development. sdp embryos exhibit no neurog1 expression in DRG precursors as assessed by a neurog1:egfp transgenic line (Fig. 1A-B′) and by in situ hybridization for neurog1 transcript (Fig. 1C-D′). In addition, no cells in the periphery ectopically express these markers, nor are any ectopic neurons revealed by Elavl1 staining, suggesting that the sdp phenotype is not caused by DRG displacement. By contrast, neurog1 expression in the central nervous system and cranial placodes appears normal. These results suggest that the sdp phenotype is a result of a defect occurring upstream of neurog1.

Neurons and glia of the zebrafish DRG are derived from a common subpopulation of neural crest (Raible and Eisen, 1994; McGraw et al., 2008). The sdp phenotype could be caused by a failure to specify this neuroglial lineage or by a later defect in neuronal differentiation. To address this question, we generated the transgenic line Tg(sox10:eos), in which the fluorophore Eos (Wiedenmann et al., 2004) is expressed under the control of the promoter for sox10, an SRY box-containing transcription factor expressed in neural crest and maintained in crest-derived glial cells (Carney et al., 2006). Schwann cells apposed to motor axons are retained in sdp embryos; however, satellite glia adjacent to DRG are notably absent (Fig. 1E,E′). Schwann cells are also found to be normally distributed along the lateral line nerve (supplementary material Fig. S2E,H). We conclude that in sdp mutants DRG neuron formation is compromised rather than specification of the neuroglial lineage.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

sdp alleles exhibit lesions in the reck coding sequence. (A) Physical map of the end of chromosome 24. sdp critical region (red line) contained at least four genes; simple sequence length polymorphism (SSLP) markers used for mapping are shown and locations of lesions indicated. (B) Predicted protein product zebrafish reck is 956 amino acids long and has an N-terminal signal sequence and two Kazal motifs. (C) Electropherograms showing each of the reck single nucleotide polymorphisms (SNPs). sdpw12 is a splice site mutation at the exon 9-intron 9 boundary, sdpw13 is a C38R substitution in exon 2, sdpw14 is a W252X substitution in exon 9. (C′) sdpw15 is a large deletion of chromosome 24 encompassing at least 0.4 Mb and including the entire sdp critical region.

All sdp alleles have sequence polymorphisms in the reck gene

To identify the genomic location of sdp alleles, we used recombination mapping in an sdpw12/Wik hybrid background. We identified a critical region of ∼200 kb on chromosome 24 associated with sdp (Fig. 2A). Direct sequencing of sdpw12 cDNA corresponding to transcripts in this region identified a mutation in the exon 9 splice donor of reck that caused a 510 bp intron to be retained (Fig. 2C). This intron contains a stop codon, which would truncate any translated protein to 309 amino acids. reck encodes a 956 amino acid protein containing an N-terminal signal sequence and two Kazal motifs (Fig. 2B); it is a glycosylphosphatidylinositol (GPI)-linked inhibitor of metalloproteinases (Takahashi et al., 1998). All sdp alleles possessed perturbations in the reck sequence (Fig. 2B-C′): a C38R missense mutation in a highly conserved residue (sdpw13), a W252X premature stop mutation (sdpw14) and a 0.5 Mb deletion of chromosome 24 that eliminates at least four other genes in addition to reck (sdpw15). Although each sdp allele possesses a different lesion in reck, they are equivalent with respect to the DRG phenotype (supplementary material Fig. S1). Complementation analysis reveals that w12, w13 and w14 are likely to be null alleles as no additional phenotypes were observed when crossed to the w15 deficiency (not shown). The severe swelling phenotype of the w15 deficiency (supplementary material Fig. S1) is reduced by complementation, suggesting that this phenotype is affected by loss of additional genes found in the interval.

Metalloproteinases are upregulated in sdp embryos

Reck inhibits the maturation and activity of the metalloproteinases Mmp2, Mmp9, Mmp14 and Adam10 (Muraguchi et al., 2007; Oh et al., 2001; Takahashi et al., 1998). We incubated protein extracts from 48 hpf sdpw12/w12 and sibling embryos with a fluorescein/gelatin conjugate, and found that mutant embryos exhibited greater metalloproteinase activity than siblings (supplementary material Fig. S4). Reck therefore appears to be a major inhibitor of metalloproteinases in developing zebrafish embryos.

Morpholino oligonucleotide knockdown of reck transcript phenocopies the DRG phenotype observed in sdp

To confirm that reck loss of function is the cause of the DRG phenotype observed in sdp, we generated a splice-blocking MO directed against the exon7-intron7 boundary. Embryos injected with this MO fail to develop DRG (Fig. 3A-D) despite the appropriate formation of cranial ganglia (Fig. 3C), Schwann cells (Fig. 3G), lateral line glia (Fig. 3H) and pigment cells (Fig. 3I), matching the phenotypes of reck mutants. DRG counts declined in a dose-dependent fashion (Fig. 3E). We verified that reck expression was disrupted by this MO by subjecting cDNA to quantitative RT-PCR using primers flanking intron 7 (Fig. 3F). These primers generate an amplicon of 366 bp when applied to appropriately spliced transcript; we cannot detect this amplicon in cDNA from embryos injected with reck MO. These results confirm that DRG formation fails in the absence of reck function.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Phenocopy of sdp with reck MO and rescue by expression of wild-type reck. (A-D) Mock injected (A,B) and MO-injected (C,D) 3 dpf Tg(neurog1:egfp) embryos immunostained for Elavl1. Scale bar: 500 μm in A,C; 50 μm in B,D. (E) neurog1+ DRG at 3 dpf in embryos injected with indicated doses of reck MO. Error bars represent s.d. (F) Loss of correctly spliced reck transcript with reck MO. RT–, negative control reaction without reverse transcriptase. (G-I) Tg(sox10:eos) embryo (3 dpf) injected with 1.5 ng reck MO and immunostained for Elavl1. (G) Crest-derived Schwann glia (empty arrowhead) are retained. Scale bar: 25 μm. (H) Crest-derived lateral line glia are retained. Scale bar: 50 μm. (I) Crest-derived pigment cells (melanophore shown) are retained. Scale bar: 25 μm. (J-M) Injection of 200 pg sdpw12 reck mRNA has no effect on sdpw12/+ (J) or sdpw12/w12 (L) fish. Injection of wt reck mRNA has no effect on sdpw12/+ fish (K) but rescues DRG formation in sdpw12/w12 fish (M). Scale bar: 100 μm. Arrowheads indicate DRG neurons.

Expression of reck rescues DRG in sdp embryos

To show that reintroduction of reck was sufficient to rescue the sdp phenotype, we injected wt or sdpw12 mutant mRNA into embryos derived from sdpw12/+ incrosses (Fig. 3, Table 1). Injection of mutant mRNA has no effect on mutants or siblings (Fig. 3J,L). Injection of wt reck mRNA restores DRG to wild-type levels in sdpw12/w12 embryos (Fig. 3M). Overexpression of wt reck mRNA fails to generate any observable phenotype on its own (Fig. 3K). We conclude that reck loss of function is solely responsible for the DRG defect observed in sdp.

Expression of reck is consistent with a role in the development of neural crest derivatives

We examined reck expression by in situ hybridization to identify tissues in which reck might act to influence DRG development. In situ hybridization for crestin was used to identify neural crest. In the trunk, crestin is expressed adjacent to the dorsal neural tube and in cells migrating between neural tube and somite (Fig. 4A,B, supplementary material Fig. S5C,D,I-I″′), whereas reck is expressed primarily in ventral mesoderm, consistent with a role in vasculature development (Fig. 4A,B, supplementary material Fig. S5G,H,J-J″′). However, a band of dorsal reck expression appears at 22 hpf (Fig. 4A,B, supplementary material Fig. S5G,H,J-J″′). This dorsal expression is transient, disappearing by 30 hpf (Fig. 4C,D)

To quantify the degree to which reck and crestin expression colocalize, embryos at 22 and 30 hpf were subjected to double fluorescent in situ hybridization followed by serial sectioning (Fig. 4B,D). Cells were counted as reck+, crestin+ or reck/crestin+ in each section. At 22 hpf, essentially all neural crest cells express reck. Although fewer neural crest cells are observed in posterior segments, we do not observe significant changes in reck/crestin colocalization (Fig. 4E,G). By 30 hpf, however, the expression of reck and crestin has largely separated into two separate cell populations (Fig. 4F,G); however, a small subset of cells (about three cells per hemisegment) continues to express both reck and crestin.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Injection of reck mRNA rescues sdpw12/w12 in a dose-dependent fashion

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

reck expression in neural crest cells. (A) Whole-mount zebrafish embryo (22 hpf). Dashed lines indicate the plane of section shown in B. (B) reck+ cells (red arrowheads) are present in both the developing vasculature and presumptive neural crest. A small number of crestin+ cells are also visible (green arrowhead). Most crestin+ cells are also reck+ (yellow arrowheads). Scale bar: 25 μm. (C) Whole-mount embryo (30 hpf). Dashed lines indicate the plane of the section shown in D. (D) Many reck+ cells (red arrowheads) are present in the developing vasculature. Many crestin+ cells (green arrowheads) are now apparent with few crestin+/reck+ cells (yellow arrowhead), suggesting the two markers have resolved into different populations. Scale bar: 25 μm. (E,F) Cell counts from serial sections of 22 hpf (E) and 30 hpf (F) embryos. Error bars represent s.d. Green, crestin+ cells; yellow, crestin+/reck+ cells; red, reck+ cells. (G) crestin+/reck+ cells as a proportion of all cells expressing crestin for 22 hpf (white circles) and 30 hpf (black circles) embryos. In most segments we observe significant segregation of crestin and reck expression. Error bars represent 95% confidence interval. n, notochord; nt, neural tube; s, somite.

MO-injected embryos exhibit vasculature defects

Mice with a targeted disruption of the reck locus display impaired vascular maturation and abdominal hemorrhage (Oh et al., 2001). To determine whether reck-deficient zebrafish embryos exhibit similar defects, we injected reck MO into Tg(fli1a:egfp) embryos, a transgenic reporter expressed in the endothelial cells of the vasculature (Lawson and Weinstein, 2002). Between 24 and 32 hpf, vasculature in MO-injected embryos is comparable to the vasculature of control embryos, although slightly delayed (Fig. 5A-C,G-I, supplementary material Table S1). However, by 48 hpf, moderate defects in circulation and vascular development are manifest. The parachordal vessel (PAV), a derivative of the caudal vein, often fails to form following reck knockdown (Fig. 5D,J, supplementary material Table S1). Additionally, although circulation initiates normally in MO-injected embryos, angiograms reveal poor perfusion in intersegmental vessels (Fig. 5E,K) as well as significantly impaired axial circulation (supplementary material Table S1). At 3 dpf, intracranial hemorrhage is apparent in reck-deficient embryos, suggesting that vascular integrity is also impaired (Fig. 5F,L, supplementary material Table S1). These results demonstrate that, as in mouse, loss of reck is associated with disruption of vasculature development.

The requirement for reck in DRG development is cell autonomous

Previous work has demonstrated that Reck is a GPI-linked protein that inhibits metalloproteinases in cis, blocking activity in the cell in which it is expressed (Muraguchi et al., 2007). reck is expressed in both neural crest and the environment through which it migrates, including vascular precursors that themselves have defective development. Therefore, the failure of DRG to form in the absence of reck function could be attributed either to cell environment or to incompetence in the neural crest itself. To differentiate between these possibilities, we performed transplants between MO- and mock-injected embryos.

Donor cells were derived from rhodamine-labeled Tg(neurog1:egfp) embryos and transplanted into nacre (mitfa – Zebrafish Information Network) host embryos (Lister et al., 1999); the resulting transplants were then immunostained for Elavl1. This allowed us to identify all donor cells incorporated into the transplant (rhodamine), donor cells which differentiated into sensory neurons (GFP), and all differentiated neurons in the transplant (Elavl1). Because nacre embryos lack trunk melanophores, we were able to verify whether donor cells had become neural crest by the appearance of donor-derived melanophores. Analysis was restricted to those embryos in which melanophores developed.

When cells from mock-injected embryos are deposited into mock-injected hosts, they are able to differentiate into DRG sensory neurons (Fig. 6A,B, Table 2). However, when cells from MO-injected embryos are transplanted into mock-injected embryos, they never form DRG neurons, despite the fact that donor cells frequently generate neural crest (Fig. 6C,D). Conversely, when cells from mock-injected donors are transplanted into MO-injected hosts, they form DRG neurons readily but are unable to induce host cells to form DRG neurons (Fig. 6E,F). Therefore, we conclude that reck is required cell autonomously in migrating neural crest for normal DRG formation.

Altered neural crest migration after perturbation of reck

Prior work has established that suppression of reck function leads to hypermigratory behavior in several cell lines (Chang et al., 2006; Liu et al., 2003; Morioka et al., 2009; Yoshida et al., 2008); conversely, forced expression of reck reduces migration (Hsu et al., 2006; Kang et al., 2007; Liu et al., 2003; Morioka et al., 2009; Silveira Corrêa et al., 2010; Yoshida et al., 2008). We hypothesized that reck loss of function might cause the neural crest to migrate excessively, causing the DRG deficit observed in sdp. We first measured the dorsoventral migration of neural crest streams at 24 hpf and found no significant difference in neural crest migration distance (supplementary material Fig. S6), suggesting that the overall extent of migration is not perturbed.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

reck-deficient embryos exhibit defects in vascularization. Mock-injected (A-F) and reck MO-injected (G-L) zebrafish embryos. (A,G) Tg(fli1a:egfp) zebrafish embryo (24 hpf) immunostained for Elavl1. Line indicates plane of image in B,H; box indicates area of image in C,I. Scale bars: 250 μm. (B,H) Cranial vasculature. AA1, mandibular arch; ACeV, anterior cerebral vein; MeCV, middle cerebral vein; PHBC, primordial hindbrain channel. Scale bars: 100 μm. (C,I) Trunk vasculature. DA, dorsal aorta; PCV, posterior cardinal vein; Se, intersegmental vessel. Scale bars: 50 μm. All blood vessels form normally in MO-injected animals but are slightly delayed in their extension. (D,J) Tg(fli1a:egfp) embryo (48 hpf). DLAV, dorsal longitudinal anastomotic vessel; PAV, parachordal vessel. The PAV is reduced in size or fails to form entirely in MO-injected embryos. Scale bars: 50 μm. (E,K) Qdot angiogram of the embryo shown in D,J. Although blood flows through the DA and PCV after MO injection, blood flow is somewhat reduced in the DLAV and intersegmental vessels. Scale bars: 50 μm. (F,L) Brightfield image of 3 dpf embryo. Cranial hemorrhage (arrowhead) is visible in a significant fraction of MO-injected embryos. Scale bars: 135 μm.

We next used time-lapse microscopy to search for more subtle differences in neural crest behavior at two different stages of development. We first imaged Tg(sox10:nls-eos) embryos between 18s and 30 hpf; this interval encompasses initiation of neural crest migration (Fig. 7A-F, supplementary material Movies 1, 2). Movies were analyzed as the first neural crest cell began to migrate ventrally. The position of each sox10+ cell was manually tracked and its velocity in the dorsoventral axis was measured. We also followed cell count, proliferation and apoptosis. During the initial migration of neural crest, we found cell velocity to be ∼40% faster in reck-depleted neural crest cells (2.66±0.25 μm/10 minutes, n=40 cells versus 1.88±0.24 μm/10 minutes, n=54 cells; mean ± s.e.m., P=0.028). The overall number of cells, the rate of proliferation and the rate of apoptosis are unchanged over this interval (Fig. 7C-F).

To examine migratory behavior in differentiating neural crest cells, we imaged uninjected and reck MO-injected Tg(sox10:nls-eos)/Tg(neurod:tagrfp) embryos between 30 and 60 hpf; this interval includes the overt expression of the first neuronal markers in DRG sensory neurons (Fig. 7G-L, supplementary material Movies 3, 4). The position of each sox10+ cell was manually tracked, and velocity (Fig. 7J), cell count (Fig. 7I), proliferation (Fig. 7K) and apoptosis (Fig. 7L) were measured as above. At this stage, we found cell velocity of reck-depleted neural crest cells to be half that of control cells (0.54±0.03 μm/10 minutes, n=72 cells versus 1.14±0.14 μm/10 minutes, n=163 cells; mean ± s.e.m., P=0.005). The rate of proliferation and the overall number of cells are not statistically different following reck depletion. We observed a small but significantly greater apoptotic rate in reck-depleted neural crest cells compared with that in uninjected embryos, although still too infrequent to significantly change overall cell number.

To determine whether neural crest cells are capable of inhabiting the appropriate microenvironment for DRG formation following reck depletion, we assessed the dorsoventral position of each cell at each time point (Fig. 7M). DRG precursors were previously noted to perform a dorsalward migration to the position of the future ganglion prior to differentiation (Raible and Eisen, 1994). This dorsal migration corresponds to the initiation of neurog1 expression (McGraw et al., 2008). We found that by 55 hours, 68% of crest-derived sox10+ cells observed in uninjected embryos are situated in this microenvironment, compared with only 20% in MO-injected embryos (Fig. 7M). Therefore, in the absence of reck, neural crest cells exhibit aberrant migratory behavior and fail to inhabit the appropriate position for differentiation into DRG.

DISCUSSION

The developmental phenotypes observed in our reck alleles reflect, in part, those seen in a previously published mouse knockout model (Oh et al., 2001). reck is expressed in the zebrafish vasculature up to and including 48 hpf (data not shown). We observe no overall gross deficit in trunk vasculogenesis; however, the parachordal chain fails to form in reck-deficient embryos. Additionally, reck MO-injected embryos exhibit hypoperfusion and cerebral hemorrhage, suggesting that vascular integrity is disrupted, concordant with the reported phenotypes in mouse. Zebrafish reck mutants might represent a model for studying the role of this inhibitor in vascular development, and additional phenotypes will be described elsewhere. Recently, other investigators uncovered a developmental interplay between motor neurons and the formation of the parachordal chain (Lim et al., 2011); further study of the relationship between RECK function, vasculogenesis and sensory neurogenesis might therefore be warranted. Nonetheless, expression and mosaic analysis suggest that reck acts within the neural crest population to regulate the formation of sensory neurons.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

DRG defects from reck depletion are cell-autonomous. (A) Mock-injected zebrafish embryo (3 dpf) implanted with mock-injected cells. Four host-derived DRG are visible (empty arrowheads) flanking one donor-derived DRG (filled arrowhead). Scale bar: 50 μm. (B) High magnification image of the donor-derived DRG shown in A. Scale bar: 25 μm. (C) Mock-injected embryo (3 dpf) implanted with MO-injected cells. Five host-derived DRG are visible (empty arrowheads), but donor cells never give rise to DRG. Scale bar: 50 μm. (D) High magnification image of one of the host-derived DRG shown in C. Scale bar: 25 μm. (E) MO-injected embryo (3 dpf) implanted with mock-injected cells. Only donor-derived DRG (filled arrowheads) are present. Scale bar: 50 μm. (F) High magnification image of one of the donor-derived DRG shown in E. Scale bar: 25 μm.

There are several possible explanations for what might happen in sdp mutants to the neural crest precursors normally fated to become DRG neurons. It is possible that cells fail to express neurog1 and are re-specified. We previously found that in neurog1 mutants sensory neuron precursors instead became glia by using the neurog1:egfp transgene to track their fates (McGraw et al., 2008). As reck acts upstream of the initiation of neurog1 expression, we have no way of tracking these precursors in reck mutants. Although it is possible to sample the fates of individual zebrafish neural crest cells by single-cell injection, the cells that generate DRG neurons are only a small fraction of the trunk neural crest population. A possible change in fate would therefore be difficult to observe with statistical reliability. Although it would be of interest to track reck-expressing neural crest cells in vivo using reporter constructs, we have been unable to identify genomic elements that direct reck expression owing to the poor characterization of sequence surrounding its position at the end of chromosome 24.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Mock-injected cells can form DRG in reck morphant embryos, but reck morphant cells cannot form DRG in mock-injected embryos

An alternative possibility is that proliferation of DRG precursors is reduced following loss of reck function. Mouse embryonic fibroblasts have reduced proliferation following Reck depletion (Kitajima et al., 2010). However, we observed no significant difference in proliferation in reck-depleted neural crest cells. A third mechanism that might contribute to the sdp phenotype involves the death of DRG progenitors. In our time-lapse experiments, we observed a small increase in neural crest cell apoptosis during the interval of DRG neuron differentiation. However, apoptosis was undetectable in neural crest cells in either wild-type or mutant animals using histological techniques despite an abundance of nearby apoptotic cells, confirming that neural crest cell death is extremely rare (supplementary material Fig. S7, Table S2). Regardless, we do not view apoptosis of progenitors and inappropriate progenitor migration as being mutually exclusive mechanisms for DRG defects.

Fig. 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 7.

Alterations in migration after reck depletion. (A-F) Uninjected and MO-injected Tg(sox10:nls-eos) zebrafish embryos were imaged from 18 to 40 hpf. (A,B) Migration of reck MO-injected neural crest is generally appropriate. Scale bar: 25 μm. (C) Number of cells is not altered after MO injection. (D) Average velocity. MO-injected cells are hypermigratory compared with uninjected cells [t(92)=2.26, P=2.84E-2]. (E) Division rate is not significantly altered following reck depletion. (F) Apoptosis is a rare event and was not observed in any MO-injected embryo time-lapses (preventing statistical analysis). (G-L) To examine cell behavior during overt DRG neuronal differentiation, uninjected and MO-injected Tg(sox10:nls-eos)/Tg(neuroD:tagRFP) embryos were imaged in time-lapse from 30 to 60 hpf. (G) In uninjected embryos, a subset of the cells in the migratory stream condense just ventral to the spinal cord (bin of ±10 μm is indicated by the bracket), forming the prospective DRG (empty arrowhead). These cells will become either the initial sensory neuron or its associated satellite glia. Note that sox10+ oligodendrocytes (filled arrowheads) are visible in both conditions; they can be distinguished from neural crest by their position in the spinal cord, their spherical nuclei and their late initiation of sox10 expression. Scale bar: 25 μm. (H) Embryos injected with 1.5 ng reck MO fail to form the DRG neuroglial cluster. Other neural crest cells take up positions consistent with Schwann cells or migrate out of the field entirely. (I) Number of cells tracked per time-lapse is not different in uninjected and MO-injected embryos. (J) Average velocity. MO-injected cells are hypomigratory compared with uninjected cells [t(233)=2.79, P=5.6E-3]. (K) Division rate is not significantly altered following reck depletion. (L) MO-injected cells undergo apoptosis at a significantly greater rate than uninjected cells [t(11)=2.269, P=4.44E-2]. (M) Proportion of cells inhabiting the ±10 μm bin flanking the ventralmost extent of the spinal cord at each point in time (bracket in G,H). LLX, time point at which the lateral line crosses the imaged segment. Black, uninjected embryos; red, MO-injected embryos. Error bars are ±95% confidence interval. Significantly fewer cells localize at the ventral aspect of the spinal cord. Simple linear regression of control and MO-injected data indicates that the proportion of uninjected cells inhabiting the prospective DRG microenvironment increases over time whereas the proportion of MO-injected cells inhabiting this region decreases [F(1, 1858)=647.832, P<0.0001; control: y=2.76×10–3 x + 0.178; MO-injected: y=–3.46×10–4 x + 0.300].

reck was first identified in a large-scale screen for cDNAs capable of returning Ras-transformed cells to a flat morphology (Takahashi et al., 1998). Subsequent work has established Reck as a regulator of cell migration and invasion (Clark et al., 2007; Noda and Takahashi, 2007). Many cancers exhibit Reck downregulation via epigenetic modifications (Chang et al., 2004; Chang et al., 2006; Chang et al., 2007), transcriptional repression (Hsu et al., 2006; Liu et al., 2003; Sasahara et al., 1999), post-translational modifications (Simizu et al., 2005) or endogenous microRNAs (Gabriely et al., 2008; Liu et al., 2010). In general, RECK expression is negatively correlated with tumor aggressiveness (Clark et al., 2011; Gabriely et al., 2008; Li et al., 2007; Masui et al., 2003; Rabien et al., 2007; Rabien et al., 2011; Song et al., 2006; Span et al., 2003; Takemoto et al., 2007; Takenaka et al., 2004; Takenaka et al., 2005; Takeuchi et al., 2004; van der Jagt et al., 2006; Xu et al., 2010); presumably in the absence of RECK, metalloproteinase hyperactivity enables greater tumor cell migration and invasion.

Like cancer cells, neural crest cells migrate through the extracellular environment to reach their final targets. One possible explanation for the DRG phenotype caused by result of reck loss of function is that neurogenic neural crest migrates inappropriately. We observed broad reck expression in neural crest cells at 22 hpf followed by restriction to a subset of neural crest cells by 30 hpf, suggesting that winnowing of reck expression might confer DRG progenitor identity as development progresses. We found that the requirement for reck is cell autonomous, a result that was somewhat surprising given the extensive expression of reck transcript in cells situated in the path of neural crest migration and the large increase in metalloproteinase activity in sdp embryos, suggesting that it is broadly active in tissues besides neural crest. Reck has been shown to inhibit metalloproteinases in cis (Muraguchi et al., 2007), suggesting that a potential metalloproteinase, the inhibition of which is crucial for normal DRG development, might be expressed within the neural crest itself, consistent with a cell-autonomous function. However, we cannot rescue the sdp defect by treating with several broad-spectrum inhibitors of metalloproteinases (supplementary material Fig. S9), although the efficacy of these inhibitors against specific zebrafish metalloproteinases is unknown. Whether any of the >50 zebrafish metalloproteinases interact with Reck awaits further analysis.

When viewed by time-lapse microscopy, reck-depleted cells exhibit changes in migratory behavior. Initially, we observed neural crest to be hypermigratory in reck MO-injected embryos, showing a small but significant increase in cell velocity. We note that we are unable to determine whether these differences reflect changes in behavior of all neural crest cells or only a subset. When viewed at later times, reck-depleted cells appear hypomigratory, in contrast to their earlier behavior. These results can be reconciled by a model in which reck-deficient cells initially show increased migration, as predicted from the cancer literature. In the absence of reck function, DRG precursors would then be re-specified (or die), leaving only slow-moving cells on the medial pathway destined to become Schwann glia. A subset of neural crest-derived sox10+ cells are unambiguously mislocalized following reck depletion, failing to move dorsally. These include neuronal precursors and cells that will form satellite glia surrounding the DRG. However, dorsal migration occurs after initial expression of neurog1, and both the failure of dorsal movement to form DRG and subsequent accumulation of satellite cells might be caused indirectly by neurog1 absence in reck mutants. Whether the lack of dorsal movement at this later stage is due to altered Reck function or whether it is the consequence of failed specification will await further study.

An alternative possibility for the function of reck in DRG specification is that altered activity of metalloproteinases could affect signaling required for neuron specification (reviewed by Bai and Pfaff, 2011). In the mouse, Reck regulates cortical neurogenesis through Notch signaling (Muraguchi et al., 2007). When Reck is disrupted, hyperactive ADAM10 results in reduced Notch signaling and precocious neurogenesis with an ultimate decrease in neurons due to precursor depletion. Might a similar impairment be the mechanism by which sdp embryos fail to form DRG? Disruption in Notch signaling results in a decrease in DRG (Cornell and Eisen, 2000; Cornell and Eisen, 2002), but this phenotype is the result of prior depletion in all trunk neural crest with concomitant increase in Rohon-Béard sensory neurons. We observe no change in Rohon-Béard cells in mutant embryos (supplementary material Fig. S8) and normal crest formation and differentiation (supplementary material Fig. S1). Moreover, loss of zebrafish notch1a receptor causes an increase in DRG neurons (Gray et al., 2001), more consistent with the neurogenic phenotype expected with loss of Notch function. Does sdp instead behave as a mutation resulting in Notch gain of function? We are unable to rescue DRG formation by treating sdp embryos with the Notch inhibitor DAPT (Geling et al., 2002) although we see an increase in DRG neurons when treating wild-type animals (data not shown), consistent with the notch1a mutant phenotype. Alternatively, Reck might alter other metalloproteinases that affect signaling pathways needed for DRG differentiation.

A limited body of evidence provides clues as to how reck might fit into a genetic hierarchy controlling DRG development. erbb2 and erbb3b function have previously been shown to be essential to the formation of DRG neurons upstream of neurog1 expression; migrating neural crest in these mutants becomes progressively disorganized and DRG precursors apparently fail to pause and differentiate (Honjo et al., 2008). ErbB2 is known to regulate Reck expression via ERK signaling (Hsu et al., 2006), and the loss of DRG observed in both erbb2 and reck mutants suggests that the two genes might act within a common signaling cascade to direct DRG formation. However, mutations affecting Erbb signaling also disrupt glial development (Lyons et al., 2005), suggesting that this pathway might affect DRG development at an earlier step involving the neuroglial precursor.

Taken together, our results suggest that Reck cell autonomously regulates the initial specification of DRG precursors upstream of neurog1. reck expression is restricted to a subset of neural crest, suggesting that these cells might represent DRG precursors. DRG cell fate choice might, therefore, rely on regulation of reck expression. Understanding which metalloproteinases are inhibited by Reck during zebrafish neural crest development will be crucial for resolving the mechanisms underlying how it regulates neural crest cell fate.

Acknowledgments

The authors wish to thank Adrienne Mueller, William Wood and Andrew Millspaugh for their assistance in writing MatLab modules. We also wish to thank Sarah Kucenas for generously providing the anti-Sox10 antibody. We thank the Sanger Centre for help with assembly of the distal end of chromosome 24.

Footnotes

  • Funding

    This investigation was supported in part by the National Institute of General Medical Sciences [NRSA 2T32 GM007270]; the National Institute of Neurological Disorders and Stroke [NS057220]; and the intramural program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD001011 to B.W.]. Deposited in PMC for release after 12 months.

  • Competing interests statement

    The authors declare no competing financial interests.

  • Supplementary material

    Supplementary material available online at http://dev.biologists.org/lookup/suppl/doi:10.1242/dev.072439/-/DC1

  • Accepted January 11, 2012.
  • © 2012.

References

  1. ↵
    1. Andermann P.,
    2. Ungos J.,
    3. Raible D. W.
    (2002). Neurogenin1 defines zebrafish cranial sensory ganglia precursors. Dev. Biol. 251, 45–58.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Bahary N.,
    2. Davidson A.,
    3. Ransom D.,
    4. Shepard J.,
    5. Stern H.,
    6. Trede N.,
    7. Zhou Y.,
    8. Barut B.,
    9. Zon L. I.
    (2004). The Zon laboratory guide to positional cloning in zebrafish. Methods Cell Biol. 77, 305–329.
    OpenUrlPubMedWeb of Science
  3. ↵
    1. Bai G.,
    2. Pfaff S. L.
    (2011). Protease regulation: the yin and yang of neural development and disease. Neuron 72, 9–21.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Carney T. J.,
    2. Dutton K. A.,
    3. Greenhill E.,
    4. Delfino-Machín M.,
    5. Dufourcq P.,
    6. Blader P.,
    7. Kelsh R. N.
    (2006). A direct role for Sox10 in specification of neural crest-derived sensory neurons. Development 133, 4619–4630.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Chang H.-C.,
    2. Liu L.-T.,
    3. Hung W.-C.
    (2004). Involvement of histone deacetylation in ras-induced down-regulation of the metastasis suppressor RECK. Cell Signal. 16, 675–679.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Chang H.-C.,
    2. Cho C.-Y.,
    3. Hung W.-C.
    (2006). Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. Cancer Res. 66, 8413–8420.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Chang H.-C.,
    2. Cho C.-Y.,
    3. Hung W.-C.
    (2007). Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer. Cancer Sci. 98, 169–173.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Clark J. C. M.,
    2. Thomas D. M.,
    3. Choong P. F. M.,
    4. Dass C. R.
    (2007). RECK – a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev. 26, 675–683.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. Clark J. C. M.,
    2. Akiyama T.,
    3. Thomas D. M.,
    4. Labrinidis A.,
    5. Evdokiou A.,
    6. Galloway S. J.,
    7. Kim H.-S.,
    8. Dass C. R.,
    9. Choong P. F. M.
    (2011). RECK in osteosarcoma. Cancer 117, 3517–3528.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Cornell R. A.,
    2. Eisen J. S.
    (2000). Delta signaling mediates segregation of neural crest and spinal sensory neurons from zebrafish lateral neural plate. Development 127, 2873–2882.
    OpenUrlAbstract
  11. ↵
    1. Cornell R. A.,
    2. Eisen J. S.
    (2002). Delta/Notch signaling promotes formation of zebrafish neural crest by repressing Neurogenin 1 function. Development 129, 2639–2648.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Fisher S.,
    2. Grice E. A.,
    3. Vinton R. M.,
    4. Bessling S. L.,
    5. Urasaki A.,
    6. Kawakami K.,
    7. McCallion A. S.
    (2006). Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish. Nat. Protoc. 1, 1297–1305.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Gabriely G.,
    2. Wurdinger T.,
    3. Kesari S.,
    4. Esau C. C.,
    5. Burchard J.,
    6. Linsley P. S.,
    7. Krichevsky A. M.
    (2008). MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 28, 5369–5380.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Gans C.,
    2. Northcutt R. G.
    (1983). Neural crest and the origin of vertebrates: a new head. Science 220, 268–273.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Geling A.,
    2. Steiner H.,
    3. Willem M.,
    4. Bally-Cuif L.,
    5. Haass C.
    (2002). A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 3, 688–694.
    OpenUrlAbstract
  16. ↵
    1. Gray M.,
    2. Moens C. B.,
    3. Amacher S. L.,
    4. Eisen J. S.,
    5. Beattie C. E.
    (2001). Zebrafish deadly seven functions in neurogenesis. Dev. Biol. 237, 306–323.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Greenwood A. L.,
    2. Turner E. E.,
    3. Anderson D. J.
    (1999). Identification of dividing, determined sensory neuron precursors in the mammalian neural crest. Development 126, 3545–3559.
    OpenUrlAbstract
  18. ↵
    1. Henion P. D.,
    2. Raible D. W.,
    3. Beattie C. E.,
    4. Stoesser K. L.,
    5. Weston J. A.,
    6. Eisen J. S.
    (1996). Screen for mutations affecting development of zebrafish neural crest. Dev. Genet. 18, 11–17.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Honjo Y.,
    2. Kniss J.,
    3. Eisen J. S.
    (2008). Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neurons. Development 135, 2615–2625.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Hsu M.-C.,
    2. Chang H.-C.,
    3. Hung W.-C.
    (2006). HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion. J. Biol. Chem. 281, 4718–4725.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Kamei M.,
    2. Isogai S.,
    3. Pan W.,
    4. Weinstein B. M.
    (2010). Imaging blood vessels in the zebrafish. Methods Cell Biol. 100, 27–54.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Kang H.-G.,
    2. Kim H.-S.,
    3. Kim K.-J.,
    4. Oh J. H.,
    5. Lee M.-R.,
    6. Seol S. M.,
    7. Han I.
    (2007). RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness. J. Orthop. Res. 25, 696–702.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Kimmel C. B.,
    2. Ballard W. W.,
    3. Kimmel S. R.,
    4. Ullmann B.,
    5. Schilling T. F.
    (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253–310.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Kitajima S.,
    2. Miki T.,
    3. Takegami Y.,
    4. Kido Y.,
    5. Noda M.,
    6. Hara E.,
    7. Shamma A.,
    8. Takahashi C.
    (2010). Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling. Oncogene 30, 737–750.
    OpenUrlPubMed
  25. ↵
    1. Knecht A. K.,
    2. Bronner-Fraser M.
    (2002). Induction of the neural crest: a multigene process. Nat. Rev. Genet. 3, 453–461.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    1. Korzh V.,
    2. Sleptsova I.,
    3. Liao J.,
    4. He J.,
    5. Gong Z.
    (1998). Expression of zebrafish bHLH genes ngn1 and nrd defines distinct stages of neural differentiation. Dev. Dyn. 213, 92–104.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Kwan K. M.,
    2. Fujimoto E.,
    3. Grabher C.,
    4. Mangum B. D.,
    5. Hardy M. E.,
    6. Campbell D. S.,
    7. Parant J. M.,
    8. Yost H. J.,
    9. Kanki J. P.,
    10. Chien C.-B.
    (2007). The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs. Dev. Dyn. 236, 3088–3099.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Lawson N. D.,
    2. Weinstein B. M.
    (2002). In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307–318.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Le Douarin N.,
    2. Kalcheim C.
    (1999). The Neural Crest. Cambridge, UK: Cambridge University Press.
  30. ↵
    1. Li S.-L.,
    2. Gao D.-L.,
    3. Zhao Z.-H.,
    4. Liu Z.-W.,
    5. Zhao Q.-M.,
    6. Yu J.-X.,
    7. Chen K.-S.,
    8. Zhang Y.-H.
    (2007). Correlation of matrix metalloproteinase suppressor genes RECK, VEGF, and CD105 with angiogenesis and biological behavior in esophageal squamous cell carcinoma. World J. Gastroenterol. 13, 6076–6081.
    OpenUrlCrossRefPubMedWeb of Science
  31. ↵
    1. Lim A. H.,
    2. Suli A.,
    3. Yaniv K.,
    4. Weinstein B.,
    5. Li D. Y.,
    6. Chien C. B.
    (2011). Motoneurons are essential for vascular pathfinding. Development 138, 3847–3857.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Lister J. A.,
    2. Robertson C. P.,
    3. Lepage T.,
    4. Johnson S. L.,
    5. Raible D. W.
    (1999). nacre encodes a zebrafish microphthalmia-related protein that regulates neural-crest-derived pigment cell fate. Development, 126, 3757–3767.
    OpenUrlAbstract
  33. ↵
    1. Liu C.,
    2. Yu J.,
    3. Yu S.,
    4. Lavker R. M.,
    5. Cai L.,
    6. Liu W.,
    7. Yang K.,
    8. He X.,
    9. Chen S.
    (2010). MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J. Hepatol. 53, 98–107.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Liu L.-T.,
    2. Peng J.-P.,
    3. Chang H.-C.,
    4. Hung W.-C.
    (2003). RECK is a target of Epstein-Barr virus latent membrane protein 1. Oncogene 22, 8263–8270.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Lyons D. A.,
    2. Pogoda H.-M.,
    3. Voas M. G.,
    4. Woods I. G.,
    5. Diamond B.,
    6. Nix R.,
    7. Arana N.,
    8. Jacobs J.,
    9. Talbot W. S.
    (2005). erbb3 and erbb2 are essential for schwann cell migration and myelination in zebrafish. Curr. Biol. 15, 513–524.
    OpenUrlCrossRefPubMedWeb of Science
  36. ↵
    1. Ma Q.,
    2. Fode C.,
    3. Guillemot F.,
    4. Anderson D. J.
    (1999). Neurogenin1 and neurogenin2 control two distinct waves of neurogenesis in developing dorsal root ganglia. Genes Dev. 13, 1717–1728.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Marusich M. F.,
    2. Furneaux H. M.,
    3. Henion P. D.,
    4. Weston J. A.
    (1994). Hu neuronal proteins are expressed in proliferating neurogenic cells. J. Neurobiol. 25, 143–155.
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    1. Masui T.,
    2. Doi R.,
    3. Koshiba T.,
    4. Fujimoto K.,
    5. Tsuji S.,
    6. Nakajima S.,
    7. Koizumi M.,
    8. Toyoda E.,
    9. Tulachan S.,
    10. Ito D.,
    11. et al
    . (2003). RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis. Clin. Cancer Res. 9, 1779–1784.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. McGraw H. F.,
    2. Nechiporuk A.,
    3. Raible D. W.
    (2008). Zebrafish dorsal root ganglia neural precursor cells adopt a glial fate in the absence of neurogenin1. J. Neurosci. 28, 12558–12569.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Morioka Y.,
    2. Monypenny J.,
    3. Matsuzaki T.,
    4. Shi S.,
    5. Alexander D. B.,
    6. Kitayama H.,
    7. Noda M.
    (2009). The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts. Oncogene 28, 1454–1464.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Muraguchi T.,
    2. Takegami Y.,
    3. Ohtsuka T.,
    4. Kitajima S.,
    5. Chandana E. P. S.,
    6. Omura A.,
    7. Miki T.,
    8. Takahashi R.,
    9. Matsumoto N.,
    10. Ludwig A.,
    11. et al
    . (2007). RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat. Neurosci. 10, 838–845.
    OpenUrlCrossRefPubMedWeb of Science
  42. ↵
    1. Noda M.,
    2. Takahashi C.
    (2007). Recklessness as a hallmark of aggressive cancer. Cancer Sci. 98, 1659–1665.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Oh J.,
    2. Takahashi R.,
    3. Kondo S.,
    4. Mizoguchi A.,
    5. Adachi E.,
    6. Sasahara R. M.,
    7. Nishimura S.,
    8. Imamura Y.,
    9. Kitayama H.,
    10. Alexander D. B.,
    11. et al
    . (2001). The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107, 789–800.
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    1. Perez S. E.,
    2. Rebelo S.,
    3. Anderson D. J.
    (1999). Early specification of sensory neuron fate revealed by expression and function of neurogenins in the chick embryo. Development 126, 1715–1728.
    OpenUrlAbstract
  45. ↵
    1. Rabien A.,
    2. Burkhardt M.,
    3. Jung M.,
    4. Fritzsche F.,
    5. Ringsdorf M.,
    6. Schicktanz H.,
    7. Loening S. A.,
    8. Kristiansen G.,
    9. Jung K.
    (2007). Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy. Eur. Urol. 51, 1259–1266.
    OpenUrlCrossRefPubMedWeb of Science
  46. ↵
    1. Rabien A.,
    2. Ergün B.,
    3. Erbersdobler A.,
    4. Jung K.,
    5. Stephan C.
    (2011). RECK overexpression decreases invasive potential in prostate cancer cells. Prostate doi: 10.1002/pros.21498.
  47. ↵
    1. Raible D. W.,
    2. Eisen J. S.
    (1994). Restriction of neural crest cell fate in the trunk of the embryonic zebrafish. Development 120, 495–503.
    OpenUrlAbstract
  48. ↵
    1. Rubinstein A. L.,
    2. Lee D.,
    3. Luo R.,
    4. Henion P. D.,
    5. Halpern M. E.
    (2000). Genes dependent on zebrafish cyclops function identified by AFLP differential gene expression screen. Genesis, 26, 86–97.
    OpenUrlCrossRefPubMedWeb of Science
  49. ↵
    1. Sasahara R. M.,
    2. Takahashi C.,
    3. Noda M.
    (1999). Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem. Biophys. Res. Commun. 264, 668–675.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Silveira Corrêa T. C.,
    2. Massaro R. R.,
    3. Brohem C. A.,
    4. Taboga S. R.,
    5. Lamers M. L.,
    6. Santos M. F.,
    7. Maria-Engler S. S.
    (2010). RECK-mediated inhibition of glioma migration and invasion. J. Cell. Biochem. 110, 52–61.
    OpenUrlPubMed
  51. ↵
    1. Simizu S.,
    2. Takagi S.,
    3. Tamura Y.,
    4. Osada H.
    (2005). RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines. Cancer Res. 65, 7455–7461.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Solnica-Krezel L.,
    2. Schier A. F.,
    3. Driever W.
    (1994). Efficient recovery of ENU-induced mutations from the zebrafish germline. Genetics 136, 1401–1420.
    OpenUrlPubMedWeb of Science
  53. ↵
    1. Song S. Y.,
    2. Son H. J.,
    3. Nam E.,
    4. Rhee J. C.,
    5. Park C.
    (2006). Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer. Eur. J. Cancer 42, 101–108.
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Span P. N.,
    2. Sweep C. G. J.,
    3. Manders P.,
    4. Beex L. V. A. M.,
    5. Leppert D.,
    6. Lindberg R. L. P.
    (2003). Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma. Cancer 97, 2710–2715.
    OpenUrlCrossRefPubMedWeb of Science
  55. ↵
    1. Szabo A.,
    2. Dalmau J.,
    3. Manley G.,
    4. Rosenfeld M.,
    5. Wong E.,
    6. Henson J.,
    7. Posner J. B.,
    8. Furneaux H. M.
    (1991). HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal. Cell 67, 325–333.
    OpenUrlCrossRefPubMedWeb of Science
  56. ↵
    1. Takahashi C.,
    2. Sheng Z.,
    3. Horan T. P.,
    4. Kitayama H.,
    5. Maki M.,
    6. Hitomi K.,
    7. Kitaura Y.,
    8. Takai S.,
    9. Sasahara R. M.,
    10. Horimoto A.,
    11. et al
    . (1998). Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc. Natl. Acad. Sci. USA 95, 13221–13226.
    OpenUrlAbstract/FREE Full Text
  57. ↵
    1. Takemoto N.,
    2. Tada M.,
    3. Hida Y.,
    4. Asano T.,
    5. Cheng S.,
    6. Kuramae T.,
    7. Hamada J.-I.,
    8. Miyamoto M.,
    9. Kondo S.,
    10. Moriuchi T.
    (2007). Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung. Lung Cancer 58, 376–383.
    OpenUrlCrossRefPubMedWeb of Science
  58. ↵
    1. Takenaka K.,
    2. Ishikawa S.,
    3. Kawano Y.,
    4. Yanagihara K.,
    5. Miyahara R.,
    6. Otake Y.,
    7. Morioka Y.,
    8. Takahashi C.,
    9. Noda M.,
    10. Wada H.,
    11. et al
    . (2004). Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer. Eur. J. Cancer 40, 1617–1623.
    OpenUrlCrossRefPubMedWeb of Science
  59. ↵
    1. Takenaka K.,
    2. Ishikawa S.,
    3. Yanagihara K.,
    4. Miyahara R.,
    5. Hasegawa S.,
    6. Otake Y.,
    7. Morioka Y.,
    8. Takahashi C.,
    9. Noda M.,
    10. Ito H.,
    11. et al
    . (2005). Prognostic significance of reversion-inducing cysteine-rich protein with Kazal motifs expression in resected pathologic stage IIIA N2 non-small-cell lung cancer. Ann. Surg. Oncol. 12, 817–824.
    OpenUrlCrossRefPubMedWeb of Science
  60. ↵
    1. Takeuchi T.,
    2. Hisanaga M.,
    3. Nagao M.,
    4. Ikeda N.,
    5. Fujii H.,
    6. Koyama F.,
    7. Mukogawa T.,
    8. Matsumoto H.,
    9. Kondo S.,
    10. Takahashi C.,
    11. et al
    . (2004). The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. Clin. Cancer Res. 10, 5572–5579.
    OpenUrlAbstract/FREE Full Text
  61. ↵
    1. Thisse C.,
    2. Thisse B.
    (2008). High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat. Protoc. 3, 59–69.
    OpenUrlCrossRefPubMedWeb of Science
  62. ↵
    1. Ungos J. M.,
    2. Karlstrom R. O.,
    3. Raible D. W.
    (2003). Hedgehog signaling is directly required for the development of zebrafish dorsal root ganglia neurons. Development 130, 5351–5362.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. van der Jagt M. F. P.,
    2. Sweep F. C. G. J.,
    3. Waas E. T.,
    4. Hendriks T.,
    5. Ruers T. J. M.,
    6. Merry A. H. H.,
    7. Wobbes T.,
    8. Span P. N.
    (2006). Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer. Cancer Lett. 237, 289–297.
    OpenUrlCrossRefPubMedWeb of Science
  64. ↵
    1. Vize P. D.,
    2. McCoy K. E.,
    3. Zhou X.
    (2009). Multichannel wholemount fluorescent and fluorescent/chromogenic in situ hybridization in Xenopus embryos. Nat. Protoc. 4, 975–983.
    OpenUrlCrossRefPubMed
  65. ↵
    1. Weinstein B. M.,
    2. Stemple D. L.,
    3. Driever W.,
    4. Fishman M. C.
    (1995). Gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat. Med. 1, 1143–1147.
    OpenUrlCrossRefPubMedWeb of Science
  66. ↵
    1. Westerfield M.
    (2007). The Zebrafish Book. Eugene, OR: University of Oregon Press.
  67. ↵
    1. Wiedenmann J.,
    2. Ivanchenko S.,
    3. Oswald F.,
    4. Schmitt F.,
    5. Röcker C.,
    6. Salih A.,
    7. Spindler K.-D.,
    8. Nienhaus G. U.
    (2004). EosFP, a fluorescent marker protein with UV-inducible green-to-red fluorescence conversion. Proc. Natl. Acad. Sci. USA 101, 15905–15910.
    OpenUrlAbstract/FREE Full Text
  68. ↵
    1. Xu J.,
    2. Wu S.,
    3. Shi X.
    (2010). Expression of matrix metalloproteinase regulator, RECK, and its clinical significance in osteosarcoma. J. Orthop. Res. 28, 1621–1625.
    OpenUrlCrossRefPubMedWeb of Science
  69. ↵
    1. Yoshida D.,
    2. Nomura R.,
    3. Teramoto A.
    (2008). Regulation of cell invasion and signalling pathways in the pituitary adenoma cell line, HP-75, by reversion-inducing cysteine-rich protein with kazal motifs (RECK). J. Neurooncol. 89, 141–150.
    OpenUrlCrossRefPubMed
View Abstract
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

 Download PDF

Email

Thank you for your interest in spreading the word on Development.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The metalloproteinase inhibitor Reck is essential for zebrafish DRG development
(Your Name) has sent you a message from Development
(Your Name) thought you would like to see the Development web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
The metalloproteinase inhibitor Reck is essential for zebrafish DRG development
Andrew Prendergast, Tor H. Linbo, Tanya Swarts, Josette M. Ungos, Hillary F. McGraw, Shlomo Krispin, Brant M. Weinstein, David W. Raible
Development 2012 139: 1141-1152; doi: 10.1242/dev.072439
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
The metalloproteinase inhibitor Reck is essential for zebrafish DRG development
Andrew Prendergast, Tor H. Linbo, Tanya Swarts, Josette M. Ungos, Hillary F. McGraw, Shlomo Krispin, Brant M. Weinstein, David W. Raible
Development 2012 139: 1141-1152; doi: 10.1242/dev.072439

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Summary
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • E2F1 regulates testicular descent and controls spermatogenesis by influencing WNT4 signaling
  • Androgen action in cell fate and communication during prostate development at single-cell resolution
  • A csf1rb mutation uncouples two waves of microglia development in zebrafish
Show more RESEARCH ARTICLES

Similar articles

Other journals from The Company of Biologists

Journal of Cell Science

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

Kathryn Virginia Anderson (1952-2020)

Developmental geneticist Kathryn Anderson passed away at home on 30 November 2020. Tamara Caspary, a former postdoc and friend, remembers Kathryn and her remarkable contribution to developmental biology.


Zooming into 2021

In a new Editorial, Editor-in-Chief James Briscoe and Executive Editor Katherine Brown reflect on the triumphs and tribulations of the last 12 months, and look towards a hopefully calmer and more predictable year.


Read & Publish participation extends worldwide

Over 60 institutions in 12 countries are now participating in our Read & Publish initiative. Here, James Briscoe explains what this means for his institution, The Francis Crick Institute. Find out more and view our full list of participating institutions.


Upcoming special issues

Imaging Development, Stem Cells and Regeneration
Submission deadline: 30 March 2021
Publication: mid-2021

The Immune System in Development and Regeneration
Guest editors: Florent Ginhoux and Paul Martin
Submission deadline: 1 September 2021
Publication: Spring 2022

Both special issues welcome Review articles as well as Research articles, and will be widely promoted online and at key global conferences.


Development presents...

Our successful webinar series continues into 2021, with early-career researchers presenting their papers and a chance to virtually network with the developmental biology community afterwards. Sign up to join our next session:

10 February
Time: 13:00 (GMT)
Chaired by: preLights

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Sign up for alerts

About us

  • About Development
  • About the Node
  • Editors and board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • Biology Open transfer

Journal info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact Development
  • Subscriptions
  • Advertising
  • Feedback

 Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992